Consumers should not purchase or use the diet pill called PAYA Dietary Supplement because a laboratory analysis conducted by the Food and Drug Administration (FDA) confirmed that the product contains a hidden drug that puts consumers’ lives at risk. The product was identified by the FDA during an examination of international mail shipments.
The PAYA Dietary Supplement is laced with sibutramine, a controlled substance that was pulled from the market in October 2010 for safety reasons. Sibutramine was marketed as an anti-obesity drug under the brand name Meridia, but was banned after a clinical trial revealed that those taking the drug were at an increased risk of heart attack and stroke.
Sibutramine is known to substantially increase blood pressure and/or heart rate in some individuals and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. Sibutramine may also interact, in life-threatening ways, with other medications a person may be taking.
Consumers who have used these products and suffered side effects should talk with their doctors. Any adverse events should also be reported to the FDA MedWatch Adverse Event Reporting Program at www.FDA.gov/MedWatch/Report.htm.
Diet pills, sexual enhancement supplements, and products used to boost athletic performance or for bodybuilding are often found to contain hidden drugs or chemicals that can put consumers’ lives at risk. The FDA is unable to test and identify all products marketed as dietary supplements that contain potentially harmful ingredients. Thus, consumers should exercise caution before purchasing these products.
Source: FDA Public Notification